ES2371762T3 - Procedimiento para la preparación de derivados de diarilcicloalquilo. - Google Patents

Procedimiento para la preparación de derivados de diarilcicloalquilo. Download PDF

Info

Publication number
ES2371762T3
ES2371762T3 ES05782434T ES05782434T ES2371762T3 ES 2371762 T3 ES2371762 T3 ES 2371762T3 ES 05782434 T ES05782434 T ES 05782434T ES 05782434 T ES05782434 T ES 05782434T ES 2371762 T3 ES2371762 T3 ES 2371762T3
Authority
ES
Spain
Prior art keywords
compound
formula
alkyl
cis
give
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05782434T
Other languages
English (en)
Spanish (es)
Inventor
Christophe Salagnad
Frank Zocher
Andreas Burgard
Bernd Junker
Rolf Hoerlein
Thomas Stuedemann
Claus-Jürgen MAIER
Jochen Hachtel
Wolfgang Holla
Christoph Tappertzhofen
Berndt Kulitzscher
Stéphane Mutti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Application granted granted Critical
Publication of ES2371762T3 publication Critical patent/ES2371762T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/03Preparation of carboxylic acid esters by reacting an ester group with a hydroxy group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/62Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems having two or more ring systems containing condensed 1,3-oxazole rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES05782434T 2004-08-23 2005-08-23 Procedimiento para la preparación de derivados de diarilcicloalquilo. Expired - Lifetime ES2371762T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004040736A DE102004040736B4 (de) 2004-08-23 2004-08-23 Verfahren zur Herstellung von Diarylcycloalkylderivaten
DE102004040736 2004-08-23

Publications (1)

Publication Number Publication Date
ES2371762T3 true ES2371762T3 (es) 2012-01-09

Family

ID=35745474

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05782434T Expired - Lifetime ES2371762T3 (es) 2004-08-23 2005-08-23 Procedimiento para la preparación de derivados de diarilcicloalquilo.

Country Status (27)

Country Link
US (2) US7803950B2 (enExample)
EP (1) EP1786913B1 (enExample)
JP (1) JP4991543B2 (enExample)
KR (1) KR20070048741A (enExample)
CN (1) CN101014714B (enExample)
AR (1) AR053760A1 (enExample)
AT (1) ATE520785T1 (enExample)
AU (1) AU2005276642B2 (enExample)
BR (1) BRPI0514000A (enExample)
CA (1) CA2578342A1 (enExample)
CY (1) CY1112080T1 (enExample)
DE (1) DE102004040736B4 (enExample)
DK (1) DK1786913T3 (enExample)
ES (1) ES2371762T3 (enExample)
IL (1) IL181339A0 (enExample)
MA (1) MA28796B1 (enExample)
MX (1) MX2007001872A (enExample)
NO (1) NO20071316L (enExample)
NZ (1) NZ553602A (enExample)
PL (1) PL1786913T3 (enExample)
PT (1) PT1786913E (enExample)
RU (1) RU2414459C2 (enExample)
SI (1) SI1786913T1 (enExample)
TW (1) TW200621734A (enExample)
UY (1) UY29082A1 (enExample)
WO (1) WO2006021420A2 (enExample)
ZA (1) ZA200700635B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
CN101381302B (zh) * 2007-09-07 2013-04-03 上海睿智化学研究有限公司 2-溴甲基-6-甲基苯甲酰氯/溴的制备方法
ES2601852T3 (es) * 2008-01-25 2017-02-16 Xenoport, Inc. Forma cristalina de sales de calcio de ácidos (3S)-aminometil-5-metil-hexanoicos y métodos de uso

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728899A (en) * 1995-03-27 1998-03-17 Hoechst Marion Roussel Inc. Preparation of cis-4-O-protected-2-cyclopentenol derivatives
US6884812B2 (en) * 2001-08-31 2005-04-26 Aventis Pharma Deutschland Gmbh Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
AU2002333456B2 (en) * 2001-08-31 2008-07-17 Sanofi-Aventis Deutschland Gmbh Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as PPAR activators
JP2005529077A (ja) * 2002-02-25 2005-09-29 イーライ・リリー・アンド・カンパニー ペルオキシソーム増殖因子活性化受容体調節物質
US7094795B2 (en) * 2003-02-27 2006-08-22 Sanofi-Aventis Deutschland Gmbh Process for preparing the enantiomeric forms of cis-configured 1,3-cyclohexanediol derivatives
DE10308353A1 (de) * 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10308350B4 (de) * 2003-02-27 2006-06-01 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 1,3-Cyclohexandiol-Derivaten
EP1689874A1 (fr) * 2003-10-22 2006-08-16 Rhodia Chimie Procede de fabrication de compose comprenant un groupement hydroxyle libre et un groupement hydroxyle protege par une fonction ester par reaction enzymatique
DE102004038403B4 (de) * 2004-08-07 2006-08-31 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 3-Hydroxycyclohexancarbonsäure-Derivaten

Also Published As

Publication number Publication date
ATE520785T1 (de) 2011-09-15
BRPI0514000A (pt) 2008-05-20
WO2006021420B1 (de) 2007-02-08
DE102004040736B4 (de) 2007-01-11
WO2006021420A3 (de) 2006-12-21
PL1786913T3 (pl) 2012-01-31
RU2007110644A (ru) 2008-09-27
NO20071316L (no) 2007-05-22
PT1786913E (pt) 2011-10-31
WO2006021420A2 (de) 2006-03-02
NZ553602A (en) 2010-04-30
JP4991543B2 (ja) 2012-08-01
EP1786913A2 (de) 2007-05-23
EP1786913B1 (de) 2011-08-17
MX2007001872A (es) 2007-04-24
UY29082A1 (es) 2006-03-31
IL181339A0 (en) 2007-07-04
US20080051583A1 (en) 2008-02-28
TW200621734A (en) 2006-07-01
CA2578342A1 (en) 2006-03-02
JP2008510761A (ja) 2008-04-10
DK1786913T3 (da) 2011-11-28
AR053760A1 (es) 2007-05-23
CN101014714A (zh) 2007-08-08
AU2005276642B2 (en) 2011-12-22
SI1786913T1 (sl) 2011-12-30
CN101014714B (zh) 2012-05-23
MA28796B1 (fr) 2007-08-01
US7803950B2 (en) 2010-09-28
DE102004040736A1 (de) 2006-03-02
CY1112080T1 (el) 2015-11-04
RU2414459C2 (ru) 2011-03-20
KR20070048741A (ko) 2007-05-09
US20070197614A1 (en) 2007-08-23
ZA200700635B (en) 2010-01-27
AU2005276642A1 (en) 2006-03-02

Similar Documents

Publication Publication Date Title
EP2537825B1 (en) Method for producing 1-amino-1-alkoxycarbonyl-2-vinylcyclopropane
CZ329792A3 (en) Process for preparing optically pure (+)-r-2-phenoxypropionic acids esters
US20070197788A1 (en) Method for the preparation of enantiomer forms of cis-configured 3-hydroxycyclohexane carboxylic acid derivatives using hydrolases
ES2371762T3 (es) Procedimiento para la preparación de derivados de diarilcicloalquilo.
ES2278305T3 (es) Proceso para preparar las formas enantiomeras de derivados de 1,3-ciclohexanodiol en configuracion cis.
WO1993006236A1 (en) Enzymatic production of optical isomers of tetrahydropyran-2-ones
KR20010066863A (ko) 에리스로-3-아미노-2-히드록시부티르산 유도체의 제조 방법
KR20070076549A (ko) 광학적으로 활성인 사이클로펜텐온의 제조방법 및 그로부터제조된 사이클로펜텐온
US20220333139A1 (en) A Chemo-Enzymatic Process for the Preparation of Homopropargylic Alcohol
Berti et al. Synthesis of optically active α-benzyl paraconic acids and their esters and assignment of their absolute configuration
JPS62272983A (ja) 3,4−エポキシ酪酸エステルから出発するl−(−)−カルニチンクロライドの製造方法
HK1105999A (en) Method for the production of diarylcycloalkyl derivatives
US7060471B2 (en) Stereoselective chemoenzymatic process for the preparation of optically enriched phenylglycidates as precursors of taxol side chain
JPWO2004092113A1 (ja) 光学活性2−アリルカルボン酸誘導体およびその製造法
JP2974181B2 (ja) シクロブタノールの新規な製造法
JPH05194299A (ja) 光学活性なグリシドール誘導体およびその製造方法
JP4608938B2 (ja) 光学活性3−アルキル−3−アリールプロピオン酸及び光学活性3−アルキル−3−アリールプロピオン酸アルキルエステルの製造方法
KR100527231B1 (ko) 무수숙신산에 의한 광학활성 1,2-디올 유도체와 이의 에스테르 제조방법
JP2000256236A (ja) 光学活性アルコール化合物の製造方法
JP2001278871A (ja) オキサゾリジン化合物およびその製造方法
US20050106692A1 (en) Process for preparation of optically active allenes
JPWO2008072764A1 (ja) 光学活性(r又はs)−ピペリジン−3−カルボン酸化合物及び光学活性(s又はr)−ピペリジン−3−カルボン酸アルキルエステル化合物の製造方法
NZ625522A (en) Novel process for the preparation of intermediates of hmg-coa reductase inhibitors
KR20010068164A (ko) 아지리딘-2-카르복시산 에스테르로부터 이소세린 및 그유도체들을 제조하는 방법
HK1104579A (en) Method for producing the enantiomer forms of cis-configured 3-hydroxycyclohexane carboxylic acid derivatives using hydrolases